Synergy Pharmaceuticals  

New York,  NY 
United States
  • Booth: 2838, S29

Please stop by Synergy's booth #2838

Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel GI therapies. Since the company's inception in 2008, we have pioneered discovery, research, and development efforts in the treatment of functional GI disorders, GI conditions, and inflammatory bowel disease. Our proprietary GI platform is based on uroguanylin, a naturally occurring human GI peptide that plays an important role in supporting normal bowel function.

Brands: Trulance

 Additional Info

DDW Tracks
Microbiome in Gastrointestinal and Liver Diseases, Inflammatory Bowel Diseases, Liver Diseases and Transplantation, Esophageal Diseases, Stomach and Small Bowel Disorders, Colorectal Diseases, Functional GI and Motility Disorders, Pancreatic Diseases, Biliary Tract Diseases
Does your company only service US attendees?

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".


For Marketing Opportunities offered by our partner TriStar, click here